A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis

NCT05849727 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

195

Enrollment

INDUSTRY

Sponsor class

Stopped Per sponsor request.

Conditions

Rheumatoid Arthritis

Interventions

DRUG: TQH3821 tablets 200 mg
DRUG: TQH3821 tablets matching placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.